Ironwood Pharmaceuticals: Q3 Of 2024 Data Readout For PBC (NASDAQ:IRWD) | Old North State Wealth News
Connect with us

Investing

Ironwood Pharmaceuticals: Q3 Of 2024 Data Readout For PBC (NASDAQ:IRWD)

Published

on

Pharrel Wiliams/iStock via Getty Images

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is expected to release data from a phase 2 study using CNP-104 for the treatment of patients with primary biliary cholangitis [PBC] in Q3 of 2024. This presents itself as one

Read the full article here

Trending

Copyright © 2024 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.